|
Federal Agencies
|
|
Office of Human Research Protections Office (OHRP)
|
|
FDA – Center for Drug Evaluation and Research (CDER)
|
|
FDA – Center for Devices and Radiological Health (CDRH)
|
|
FDA – Center for Biologics Evaluation and Research (CBER)
|
|
Center for Disease Control and Prevention
|
|
National Science Foundation (NSF)
|
|
Office of Naval Research (ONR)
|
|
Department of Defense (DOD)
|
|
Department of Education (ED)
|
|
Department of Energy (DOE)
|
|
Department of Veteran’s Affairs
|
|
U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)
|
|
U.S. Army Research Laboratory (ARL)
|
|
DHHS Office for Civil Rights - HIPAA
|
|
DHHS Office of Research Integrity
|
|
NIH Office of Biotechnology Activities (OBA)
|
|
|
| Useful Federal References |
|
FDA Information Sheet Guidances
|
|
Clinical Trials.gov
|
|
NIH and Clinical Research
|
|
DHHS Protection of Human Subjects: 45 CFR 46
|
|
FDA Protection of Human Subjects: 21 CFR 50
|
|
FDA Institutional Review Board: 21 CFR 56
|
|
FDA Investigational New Drug Application: 21 CFR 312
|
|
FDA Investigational Device Exemptions: 21 CFR 812
|
|
OHRP Guidebook
|
|
|
| State of California |
|
California Health and Human Services – Committee for the Protection of Human Subjects
|
|
Research Advisory Panel of California
|
|
California Information Practices Act, Civil Code, Section 1798.24 (SB13)
|
|
|
| Ethical Principles and Codes |
|
The Belmont Report
|
|
The Nuremberg Code
|
|
World Medical Association Declaration of Helsinki
|
|
|
| Other Useful References |
|
Collaborative IRB Training Initiative (CITI)
|
|
Guidelines for Good Clinical Practice (GCP)
|